The francophone Africa blood transfusion research network: A five-year report;Le groupe de recherches transfusionnelles d'Afrique francophone: Bilan des cinq premières années

Transfusion Clinique et Biologique

Volumn 21, Issue 1, 2014, Pages 37-42

  Tagny, Claude Tayou ^a   Murphy, Edward L ^b   Lefrère, Jean Jacques ^c  

^a Centre Hospitalier et Universitaire de Yaounde   (Cameroon)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

Africa; Research group; Transfusion

Indexed keywords

AFRICA SOUTH OF THE SAHARA; ARTICLE; BLOOD SAFETY; BLOOD TRANSFUSION; DATA ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEALTH IMPACT ASSESSMENT; HUMAN; MEDICAL RESEARCH; MEDICAL SERVICE; MEDICAL SOCIETY; ORGANIZATIONAL DOWNSIZING; ORGANIZATIONAL EFFICIENCY; OUTCOME ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; TREATMENT PLANNING; AFRICA; DONOR SELECTION; RESEARCH; TIME;

AFRICA; BLOOD SAFETY; BLOOD TRANSFUSION; DONOR SELECTION; HUMANS; RESEARCH; RESEARCH REPORT; TIME FACTORS;

EID: 84896694900     PISSN: 12467820     EISSN: 19538022     Source Type: Journal    
DOI: 10.1016/j.tracli.2013.10.002     Document Type: Article

References (23)

1. Stephen J.D. Haemoglobin and plasma-protein levels in West Africa. Trans R Soc Trop Med Hyg 1948, 41:829-831.
2. Armattoe R.E. ABO and RH blood types among the ewes of West Africa. Am J Phys Anthropol 1951, 9:371-373.
3. Tagny C.T., Mbanya D., Tapko J.B., Lefrere J.J. Blood safety in Sub-Saharan Africa: a multifactorial problem. Transfusion 2008, 48:1256-1261.
4. Tayou Tagny C., Owusu-Ofori S., Mbanya D., Deneys V. The blood donor in Sub-Saharan Africa: a review. Trans Med 2010, 20:1-10.
5. Allain J.P. Moving on from voluntary non-remunerated donors: who is the best blood donor?. Br J Haematol 2011, 10.1111/j.1365-2141.2011.08708.x.
6. Kouao M.D., Dembelé B., N'Goran L.K., Konaté S., Bloch E., Murphy E.L., et al. Reasons for blood donation deferral in sub-Saharan Africa: experience in Ivory Coast. Transfusion 2012, 52:1602-1606.
7. Dahourou H., Tapko J.B., Nébié Y., Kiénou K., Sanou M., Diallo M., et al. Implementation of hemovigilance in Sub-Saharan Africa. Transfus Clin Biol 2012, 19:39-45.
8. Nébié K., Ouattara S., Sanou M., et al. Poor procedures and quality control among non affiliated blood centers in Burkina Faso: an argument for expanding the reach of the national blood transfusion center. Transfusion 2011, 51:1613-1618.
9. Tagny C.T., Mbanya D., Leballais L., Murphy E., Lefrère J.J., Laperche S. Reduction of the risk of transfusion-transmitted human immunodeficiency virus (HIV) infection by using an HIV antigen/antibody combination assay in blood donation screening in Cameroon. Transfusion 2011, 51:184-190.
10. Diarra A., Kouriba B., Baby M., Murphy E., Lefrere J.J. HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: lower rates among volunteer blood donors. Transf Clin Biol 2009, 16:444-447.
11. Tayou Tagny C., Mbanya D., Garraud O., Lefrère J.J. Blood safety: malaria and blood donation in Africa. Transfus Clin Biol 2007, 14:481-486.
12. Tagny C.T., Diarra A., Yahaya R., et al. Characteristics of blood donors and donated blood in sub-Saharan Francophone Africa. Transfusion 2009, 49:1592-1599.
13. Laperche S., Boukatou G., Kouegnigan L., et al. Transfusion safety on the African continent: an international quality control of virus testing in blood banks. Transfusion 2009, 49:1600-1608.
14. Lefrere J.J., Dahourouh H., Dokekias A.E., et al. Estimate of the residual risk of transfusion-transmitted human immunodeficiency virus infection in sub-Saharan Africa: a multinational collaborative study. Transfusion 2011, 51:486-492.
15. Tagny C.T., Kouao M.D., Touré H., et al. Transfusion safety in francophone African countries: an analysis of strategies for the medical selection of blood donors. Transfusion 2012, 52:134-143.
16. Laperche S. Multinational assessment of blood-borne virus testing and transfusion safety on the African continent. Transfusion 2013, 53:816-826. Francophone African Group for Research in Blood Transfusion.
17. Marshall D.A., Kleinman S.H., Wong J.B., AuBuchon J.P., Grima D.T., Kulin N.A., et al. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang 2004, 86:28-40.
18. Candotti D., Sarkodie F., Allain J.P. Residual risk of transfusion in Ghana. Br J Haematol 2001, 113:37-39.
19. Loua A., Sow E.M., Magassouba F.B., Camara M., Balde M.A. Evaluation of residual infectious risk among blood donorsin National Center of Blood Transfusion in Conakry. Transf Clin Biol 2004, 11:98-100.
20. Ouattara H., Siransy-Bogui L., Fretz C., et al. Residual risk of HIV, HVB and HCV transmission by blood transfusion between 2002and 2004at the Abidjan National Blood Transfusion Center. Transf Clin Biol 2006, 13:242-245.
21. Busch M.P., Lee L.L., Satten G.A., et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1seroconversion: implications for screening of blood and tissue donors. Transfusion 1995, 35:91-97.
22. Minga A., Dohoun L., Abo Y., et al. Risk behaviors in volunteer blood donors who seroconverted for HIV, Abidjan, CÔte d'Ivoire 1997to 2005. Transfusion 2010, 50:888-893.
23. Tapko J.B., Sam O., Diarra-Nama A.J. Status of blood safety in the WHO African Region: report of the 2004survey 2007, AFRO WHO, Brazzaville.